FGL (Fibroblast Growth-Like) vs Ghrelinomimetic

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

FGL (Fibroblast Growth-Like) and Ghrelinomimetic are both healing & recovery peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares FGL (Fibroblast Growth-Like) and Ghrelinomimetic across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

FGL (Fibroblast Growth-Like)Ghrelinomimetic
CategoryHealing & RecoveryHealing & Recovery
Regulatory status (US)Research use onlyResearch use only
Typical dosage1 mg100-200 mcg
Frequencydailydaily
Reported benefitsNeuroprotection, neural repair, cognitive supportIncreased appetite, gut healing, muscle preservation
Reported side effectsResearch phase, limited dataIncreased hunger, water retention

Key differences

Primary use. FGL (Fibroblast Growth-Like) is categorised under Healing & Recovery, while Ghrelinomimetic falls under Healing & Recovery. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. FGL (Fibroblast Growth-Like): not FDA-approved; treated as a research compound. Ghrelinomimetic: not FDA-approved; treated as a research compound.

Dosing. FGL (Fibroblast Growth-Like) is typically dosed at 1 mg (daily). Ghrelinomimetic is typically dosed at 100-200 mcg (daily).

Can you stack them?

Some protocols combine peptides, but stacking FGL (Fibroblast Growth-Like) and Ghrelinomimetic has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between FGL (Fibroblast Growth-Like) and Ghrelinomimetic?
FGL (Fibroblast Growth-Like) and Ghrelinomimetic are both healing & recovery peptides, but they differ in mechanism, dosing, and regulatory status. FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound, whereas Ghrelinomimetic is not FDA-approved; generally classified as a research compound.
What is FGL (Fibroblast Growth-Like) used for?
Neural repair peptide.
What is Ghrelinomimetic used for?
Appetite and healing support.
Can you take FGL (Fibroblast Growth-Like) and Ghrelinomimetic together?
Some users combine peptides within a single protocol, but stacking FGL (Fibroblast Growth-Like) and Ghrelinomimetic has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is FGL (Fibroblast Growth-Like) or Ghrelinomimetic FDA-approved?
FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound. Ghrelinomimetic is not FDA-approved; generally classified as a research compound.

Read the full articles

More Healing & Recovery comparisons

← All peptide comparisons